Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.

<h4>Background</h4>Cholera is an acute, diarrheal disease caused by Vibrio cholerae O1 or 139 that is associated with a high global burden.<h4>Methods</h4>We analyzed the estimated duration of immunity following cholera infection from available published studies. We searched...

Full description

Bibliographic Details
Main Authors: Tiffany Leung, Laura Matrajt
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-05-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0009383
id doaj-500a662489354eeba9e469e2c1e9e71b
record_format Article
spelling doaj-500a662489354eeba9e469e2c1e9e71b2021-06-09T04:33:11ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352021-05-01155e000938310.1371/journal.pntd.0009383Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.Tiffany LeungLaura Matrajt<h4>Background</h4>Cholera is an acute, diarrheal disease caused by Vibrio cholerae O1 or 139 that is associated with a high global burden.<h4>Methods</h4>We analyzed the estimated duration of immunity following cholera infection from available published studies. We searched PubMed and Web of Science for studies of the long-term immunity following cholera infection. We identified 22 eligible studies and categorized them as either observational, challenge, or serological.<h4>Results</h4>We found strong evidence of protection at 3 years after infection in observational and challenge studies. However, serological studies show that elevated humoral markers of potential correlates of protection returned to baseline within 1 year. Additionally, a subclinical cholera infection may confer lower protection than a clinical one, as suggested by 3 studies that found that, albeit with small sample sizes, most participants with a subclinical infection from an initial challenge with cholera had a symptomatic infection when rechallenged with a homologous biotype.<h4>Conclusions</h4>This review underscores the need to elucidate potential differences in the protection provided by clinical and subclinical cholera infections. Further, more studies are warranted to bridge the gap between the correlates of protection and cholera immunity. Understanding the duration of natural immunity to cholera can help guide control strategies and policy.https://doi.org/10.1371/journal.pntd.0009383
collection DOAJ
language English
format Article
sources DOAJ
author Tiffany Leung
Laura Matrajt
spellingShingle Tiffany Leung
Laura Matrajt
Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
PLoS Neglected Tropical Diseases
author_facet Tiffany Leung
Laura Matrajt
author_sort Tiffany Leung
title Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
title_short Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
title_full Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
title_fullStr Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
title_full_unstemmed Protection afforded by previous Vibrio cholerae infection against subsequent disease and infection: A review.
title_sort protection afforded by previous vibrio cholerae infection against subsequent disease and infection: a review.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2021-05-01
description <h4>Background</h4>Cholera is an acute, diarrheal disease caused by Vibrio cholerae O1 or 139 that is associated with a high global burden.<h4>Methods</h4>We analyzed the estimated duration of immunity following cholera infection from available published studies. We searched PubMed and Web of Science for studies of the long-term immunity following cholera infection. We identified 22 eligible studies and categorized them as either observational, challenge, or serological.<h4>Results</h4>We found strong evidence of protection at 3 years after infection in observational and challenge studies. However, serological studies show that elevated humoral markers of potential correlates of protection returned to baseline within 1 year. Additionally, a subclinical cholera infection may confer lower protection than a clinical one, as suggested by 3 studies that found that, albeit with small sample sizes, most participants with a subclinical infection from an initial challenge with cholera had a symptomatic infection when rechallenged with a homologous biotype.<h4>Conclusions</h4>This review underscores the need to elucidate potential differences in the protection provided by clinical and subclinical cholera infections. Further, more studies are warranted to bridge the gap between the correlates of protection and cholera immunity. Understanding the duration of natural immunity to cholera can help guide control strategies and policy.
url https://doi.org/10.1371/journal.pntd.0009383
work_keys_str_mv AT tiffanyleung protectionaffordedbypreviousvibriocholeraeinfectionagainstsubsequentdiseaseandinfectionareview
AT lauramatrajt protectionaffordedbypreviousvibriocholeraeinfectionagainstsubsequentdiseaseandinfectionareview
_version_ 1721389286247366656